EMD p.Ser54Phe
c.161C>T · rs782764813 · VCV2675026
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1555 | likely benign |
|---|---|---|
| REVEL | 0.601 | indeterminate |
| SaProt | LLR -8.37 | tolerated |
| ⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 6.2 | GERP 1.1, phastCons 1 |
| Regional constraint | o/e 1.05 | unconstrained · MANE · 1,709 bp · p 0.47 · regional, not allelic |
| Overall | ||
| CADD | 18.74 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- EMD
- Protein
- p.Ser54Phe
- Coding
- c.161C>T
- MANE Select
- NM_000117
- dbSNP
- rs782764813
- Type
- single nucleotide variant
- Location
- chrX:154379768 (GRCh38)
- Structure
- AlphaFold pLDDT 61.26 · 6 PDB
- Residue 54
- a UniProt-annotated variant site (in edmd1; likely pathogenic; unable to rescue impaired differentiation of emd-deficient myogenic progenitor cells; no loss of binding to f-actin; enhanced rate of actin polymerization and loss of binding to bclaf1); the 'interaction with f-actin' region; a modified residue (phosphoserine)
Similar variants
- EMD p.Ser54Cys Uncertain significance ★ ⚠ same residue
- EMD p.Ser54= Likely benign ★ same residue
- EMD c.265+1G>A Likely pathogenic ★★ same condition
- EMD c.450-2A>G Pathogenic/Likely pathogenic ★★ same condition
- EMD p.Gln44Ter Pathogenic ★★ same condition
- EMD c.82+3A>G Uncertain significance ★★ same condition
- EMD p.Ala55Ser Uncertain significance ★★ ⚠ same condition
- EMD p.Arg152His Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/emd-p-ser54phe (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown